Coloplast A/S - Allocation of Share Options

Report on transactions of executives and related parties in Coloplast shares and related securities

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.

The below transactions concern allocation of share options.

For further details, reference is made to Coloplast’s Remuneration Policy. The policy is available on the group website at this address:

https://investor.coloplast.com/investor-relations/governance/policies_and_positions/

	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Kristian Villumsen
2	Reason for the notification
a)	Position/status	President & CEO
b)	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)	Name	Coloplast A/S (CVR-no.: 69749917)
b)	LEI	529900NN7SOJ5QG82X67
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Share options relating to B shares
	Identification code	ISIN: DK0060448595 (B shares)
b)	Nature of the transaction	Share option allocation
c)	Price and volume	Price	Volume
		0.00	73,690
d)	Aggregated information
	- Aggregated volume	73,690 share options
	- Price	DKK 0.00
e)	Date of the transaction	2025-02-04, 12:10 UTC
f)	Place of the transaction	Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Anders Lonning-Skovgaard
2	Reason for the notification
a)	Position/status	Executive Vice President & CFO
b)	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)	Name	Coloplast A/S (CVR-no.: 69749917)
b)	LEI	529900NN7SOJ5QG82X67
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Share options relating to B shares
	Identification code	ISIN: DK0060448595 (B shares)
b)	Nature of the transaction	Share option allocation
c)	Price and volume	Price	Volume
		0.00	37,511
d)	Aggregated information
	- Aggregated volume	37,511 share options
	- Price	DKK 0.00
e)	Date of the transaction	2025-02-04, 12:10 UTC
f)	Place of the transaction	Outside a trading venue

For further information, please contact

Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111

Aleksandra Dimovska
Vice President, Investor Relations
Tel. +45 4911 1800 / +45 4911 2458
Email: dkadim@coloplast.com

Simone Dyrby Helvind
Senior Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 2981
Email: dksdk@coloplast.com

Press and media
Peter Mønster
Sr. Media Relations Manager
Tel. +45 4911 2623
Email: dkpete@coloplast.com

Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917

Website
www.coloplast.com

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail.

Coloplast was founded on passion, ambition, and commitment. We were born from a nurse’s wish to help her sister and the skills of an engineer. Guided by empathy, our mission is to make life easier for people with intimate healthcare needs. Over decades, we have helped millions of people to live a more independent life and we continue to do so through innovative products and services. Globally, our business areas include Ostomy Care, Continence Care, Advanced Wound Care, Interventional Urology and Voice and Respiratory Care.

Attachment